Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

 quit rate to 30% at 1yr vs 16% with patches and 15.6% for placebo (patches + bupropion: 35.5%): 1 consider if the above fails. Warn of SES: seizures (risk <1:1000), insomnia, headache. Lipids and diabetes (pp690, 206) are the other major modifi able risk factors. The QRISK2 score (www.qrisk.org) is used in the UK to integrate a patient’s diff erent car- diovascular risk factors in order to predict future cardiovascular health.2 It can be used as part of a consultation on lifestyle factors to show patients that address- ing certain risk factors (eg smoking, BP) will reduce their risk of MIs and strokes. Apply preventive measures such as healthy eating (p244) early in life to maxim- ize impact, when there are most years to save, and before bad habits get ingrained. The randomized trial Cardiovascular medicine has an unrivalled treasure house of randomized trials. One of the chief pleasures of cardiovascular medicine lies in integrating these with clinical reasoning in a humane way. After a cardiac event, a protocol may ‘mandate’ statins, aspirin, -blockers, ACE-i (p114), and a target BP and LDL choles- terol that makes your patient feel dreadful. What to do? Inform, negotiate, and compromise. Never reject
